7
Participants
Start Date
September 30, 2001
Primary Completion Date
April 30, 2003
rituximab
fludarabine phosphate
Memorial Sloan-Kettering Cancer Center, New York
Long Island Jewish Medical Center, New Hyde Park
Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore
Cleveland Clinic Taussig Cancer Center, Cleveland
Rush-Presbyterian-St. Luke's Medical Center, Chicago
Arizona Cancer Center, Tucson
Cedars-Sinai Medical Center, Los Angeles
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
Walter Reed Army Medical Center, Washington D.C.
Holden Comprehensive Cancer Center, Iowa City
Tuft-New England Medical Center, Boston
Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston
Barrett Cancer Center, Cincinnati
Cross Cancer Institute, Edmonton
Chedoke-McMaster Hospitals, Hamilton
Huddinge University Hospital, Stockholm
Saint Bartholomew's Hospital, London
National Cancer Institute (NCI)
NIH
Jonsson Comprehensive Cancer Center
OTHER